600721.SH
百花医药
SSE · Consumer Cyclical · Restaurants · CN
CNY 14.19
+7.09%Year over year
Reported trailing growth
- Revenue
- -8.5%
- EBITDA
- —
- EBIT
- -20.0%
- EPS
- -36.1%
- Free cash flow
- -8.9%
- Operating cash flow
- -20.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.5%
- EBITDA
- +24.6%
- EBIT
- +57.0%
- Net income
- +77.1%
- EPS
- +76.0%
- Free cash flow
- -37.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026